Central type Ca2+ channel modulators as targets for the novel treatment of psychiatric diseases

Human Psychopharmacology

Volumn 13, Issue 8, 1998, Pages 539-542

  Watanabe, Yasuo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL AFFECTING AGENT; CALCIUM ION;

AMNESIA; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG MECHANISM; EDITORIAL; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032421734     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(1998120)13:8<539::AID-HUP37>3.0.CO;2-B     Document Type: Editorial

References (23)

1. 3H]-noradrenaline release from cultured chick sympathetic neurons. Nauyen Scmiederberg's Archives Pharmacology, 350, 258-266.
2. Betz, E. (1998). The effect of calcium antagonists on intimal cell proliferation in atherogenesis. Annals New York Academy of Sciences, 522, 399-410.
3. Bezprozvanny, I., Scheller, R. H. and Tsien, R. W. (1995). Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature, 378, 623-628.
4. Briand, V., Laurent, S., Tsoucaris-Kupfer, D., Legrand, M., Brisac, A. M. and Schmitt, H. (1988). Central and peripheral cardiovascular effects of the enantiomers of the calcium antagonist PN 20-110. European Journal of Pharmacology, 150, 43-50.
5. 2+ mobilization of spontaneously hypertensive rats under mild stress. Neuroscience Research, 12, 346-355.
6. Colado, M. I., Ormazabal, M. J., Alfaro, M. J. and Martin, M. I. (1993). Effects of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxy-tryptamine in various brain areas of the rat. Journal of Pharmacy and Pharmacology, 45, 220-222.
7. Cox, D. H. and Dunlap, K. (1992). Pharmacological discrimination of N-type calcium current and its selective modulation by transmitters. Journal of Neuroscience, 12(3), 906-914.
8. 2+ channels in mammalian central neurons. Trends in Neuroscience, 18(2), 89-98.
9. Igelmund, P., Zhao, Y. Q. and Heinemann, U. (1996). Effect of T-type, L-type, N-type, P-type and Q-type calcium channel blockers on stimulus-induced preand postsynaptic calcium fluxes in rat hippocampal slices. Experimental Brain Research, 109, 22-32.
10. 2+ channel antagonists with Vogel-type conflict test in rats. European Journal of Pharmacology, 264, 107-110.
11. Miller, R. G., Shepherd, R., Dao, H., Khramstov, A., Mendoza, M., Graves, J. and -Smith, S. (1996). Controlled trial of nimodipine in amyotrophic lateral sclerosis. Neuromuscular Disorders, 6, 101-104.
12. Moore, N. A., Rees, G., Sanger, G. and Awere, S. (1993). Effect of L-type calcium channel modulators on stimulant-induced hyperactivity. Neuropharmacology, 32, 719-720.
13. 2+ channels. Trends in Pharmacological Sciences, 11, 112-115.
14. 2+ channel blockers: multiple sites of action. Folia Pharmacologica Japonica, 100, 239-247.
15. Stain, L. S., Tavalin, S. J., Kinard, T. A. and Teague, J. (1995). Contribution of L- and non-L-type calcium channels to voltage-gated calcium current and glucose-dependent insulin secretion in HTT-T15 cells. Endocrinology, 136(10), 4589-4601.
16. 2+ antagonists. Human Psychopharmacology, 13, 389-405.
17. 2+ channels in neurons. In Neurotoxins in Neurochemistry, Dolly, J. O. (Ed.), Ellis Horwood, Chichester, pp. 162-167.
18. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proceedings of National Academy of Science, U.S.A., 90(2), 9518-9522.
19. Watanabe, Y., Hori, Y. and Ohnishi, M. (1995). Inhibitory effects of newly synthesized Ser contained GABA-peptides administered into either caudate putamen or amygdala on methamphetamine induced hyperactivity. Japanese Journal of Psychopharmacology, 15, 239-246.
20. 2+ channel in the brain. Life Sciences, 62(17/18), 1671-1675.
21. 2+ modulation of newly synthesized Ser-contained GABA-peptides related to the antipsychotic action. In Calcium Ion Modulators: The New Wave of Psychotropic Drugs, Inoue, K. and Watanabe, Y. (Eds), Harwood Academic, Switzerland, 121-184.
22. Yoshimura, Y., Watanabe, Y. and Shibuya, T. (1993). Inhibitory effects of calcium channel antagonist on motor dysfunction induced by intracerebroventicular administration of paraquat. Pharmacology and Toxicology, 72, 229-235.
23. 2+ levels increased by high-potassium or glutamate in cultured rat cerebellar granule cell. Japanese Journal of Pharmacology, 62, 411-414.